Document Page: First | Prev | Next | All | Image | This Release | Search
File: 123096_sep96_decls23_0023.txt
Subject: DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANCE
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Document Number: 1
Folder Seq #: 88
C. Control of wild canids (foxes and jackals are the
natural reservoirs of infection). MALRRIA
D. Protection of patients from further sandfly bites, thus I . Communicability:
aborting possibility of epidemics based on human
reservoirs. A. Route:
1. Disease is transmitted by bites of infected
E. Report all cases through Preventive Medicine channels. anopheline mosquitoes.
2. Transfusion of malaria-infected blood will trans-
mit disease.
3. IV drug abusers sharing contaminated needles have
become infected.
B. Isolation: Malarious patients must be protected from
exposure to additional mosquito bites. Insect repel-
lent and netting should be used. No other isolation is
required.
C. Contact prophylaxis: prophylaxis of individuals who
have had contact with malaria patients is not required
per se.
D. Chemoprophylaxis:
1. Chemoprophylaxis of all individuals present in
malaria areas should be instituted. At this time,
malaria is not known to be present in eastern
Saudi Arabia, Kuwait, or southern Iraq, however,
malaria may be introduced into these areas by
migrant workers or troops. Imported cases are
seen in this group. P. falcipa@m and E!. vivax
malaria are seen in western Saudi Arabia. Chloro-
quine-resistant strains, if present, are rare.
2. a. Recommended regimen (for western Saudi
Arabia): chloroquine phosphate (Aralen), 500
mg weekly, preferably commencing 1-2 weeks
before arrival, and continuing for 6 weeks
after departure.
b. "Teminal prophylaxis" to eradicate per-
sistent hepatic parasites should be con-
sidered for individuals who are not pregnant
or G6PD deficient: primaquine phosphate,
26.3 mg PO QD, for 14 days after departure
from malaria area. In individuals unable to
take primaquine, an additional 6 weeks (for
total of 3 months) prophylaxis with chloro-
quine may be given after departure. Terminal
prophylaxis should only be recommended if P.
been
identified in the theater.
36
37
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 52 f:/Week-36/BX003203/DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS/diagnosis and treatment of diseases of importanc:12179609281524
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Folder Seq # = 88
Subject = DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANC
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996